What changed in India?
The Star, carrying an AFP report on 25 March 2026, gave 20 March 2026 as the date the semaglutide patents expired in India and said several Indian drug makers have since launched generic semaglutide products. The same report quotes India's health ministry cautioning against unregulated use of weight-loss drugs, saying they should be used only with a doctor's prescription, and saying its regulator is stepping up surveillance and inspections across the supply chain.
A generic medicine contains the same active ingredient as an original. The point to hold on to is that each country registers products for itself, so a product launched in India has not been through Malaysia's registration unless it appears on Malaysia's register.
Does registration in India make a product registered in Malaysia?
No. The Ministry of Health's traveller's guide says: "Only pharmaceutical product inclusive vitamins and health supplements which is registered with the Drug Control Authority, Ministry of Health Malaysia (MOH) and notified cosmetic with MOH is allowed to be imported and the importation shall be done by an importer who is licensed to import such product". Its eKhidmat FAQ says: "Whether for personal use or business purposes, only products registered and cosmetics notified with the Ministry of Health Malaysia (MOH) are allowed to be imported by the product import license holder/ cosmetics notification holder into Malaysia."
The register is public, and it can be searched in a minute. On 6 November 2026 the NPRA register (QUEST3+) listed 15 semaglutide products, named Ozempic, Rybelsus or Wegovy. A product that is not on it is not a registered product here, and the Ministry's FAQ says a medicine without a MAL number is considered unregistered and is not allowed to be sold or advertised in Malaysia. The article on Reta and Mounjaro shows the same logic applied to a pen sold online.
What does the personal-use rule say?
This is the part most often half-remembered. The NPRA answers the question "Can unregistered medicines for personal use be brought into Malaysia?" in these words: "Under the Control of Drugs and Cosmetics Regulations 1984, the requirements for drug registration does not apply to a person who arrives in Malaysia and imports, as part of his personal luggage, any product for his use or his family's use, in a quantity that does not exceed one month's use by one person. In the case of importing the products by post, this will require an import exemption that is granted by the Director of Pharmacy Enforcement Division, Ministry of Health Malaysia. For further information, please contact the Pharmacy Enforcement Division near you."
Three things follow from the wording. The allowance is for a person who arrives, with the product in personal luggage. It is capped at one month's use by one person, and the Ministry's guide adds that the permissible amount "will be determined according to the medication dosage label". And the post is a different case that needs an exemption from the Director of Pharmacy Enforcement Division. The guide also says not to bring medicines in for anyone other than yourself or an immediate family member travelling with you. This article stops at the rule. It does not describe how to obtain a product, and the exemption is a matter between a person and the Pharmacy Enforcement Division.
An allowance for luggage is not a registration. It does not make the product registered, and it does not make it lawful to sell, share or resell.
What is the penalty?
The Ministry's traveller's guide states: "Upon conviction of any offences regarding importation of unregistered products or un-notified cosmetics/ importation without import licence or not by the authorized holder, the convicted offender shall be liable to a fine not exceeding RM 25,000 or imprisonment not exceeding three (3) years or both." The file on the Ministry's site is dated January 2019, so the figure should be confirmed with the Pharmacy Enforcement Division before anyone relies on it.
The eKhidmat FAQ adds a practical consequence: "All imported goods that are imported illegally into Malaysia will be detained by the Royal Malaysian Customs and will be disposed of."
Why does the registration matter if the molecule is the same?
An active ingredient name describes one part of a medicine. A registered product also has a specific formulation, manufacturer, label, package and leaflet, and the Ministry's FAQ ties registration to safety, quality and efficacy. A regulator registers products one by one for that reason. The AFP report on India is itself a caution about unregulated use, which fits.
There is a second problem. When a pen or vial arrives by an unofficial route, the buyer cannot easily tell whether it is what the label says. The article on fake pens sets out what WHO, EMA and FDA warn about, and none of it is solved by the product having a real generic name.
Where does that leave someone who wants semaglutide?
In Malaysia the registered semaglutide products are prescription medicines. The article on the legal route explains why the prescription matters, and the one on how the GLP-1 medicines differ compares what is registered for what. Whether any of them suits a person is decided at an assessment.
What does The Retreat Clinic offer?
The Retreat Clinic is a doctor-led aesthetic clinic in Setia Alam, Shah Alam. The clinic's weight management page describes a pathway that begins with a medical assessment: a history, an examination and usually blood tests. Where the assessment supports it, treatment may include prescription medicines, with follow-up for as long as treatment continues. The page says that nothing is prescribed at the assessment itself, and that Dr Ong Jin Khang declines to prescribe where the medicine does not fit.
The page does not describe medicines from abroad, and this article does not say that the clinic sources, supplies or recommends any. It sets out what the regulator has written down.
